Physician profile
Charyl Hermann
NPI 1134899206
$293.68
in general payments reported to CMS, 2019-2025
8 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $34.37 · 2024: $74.31 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $67.07 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Ionis Pharmaceuticals, INC. | $48.96 | 2025 | Tryngolza |
| Abiomed | $41.61 | 2024 | Impella |
| Bridgebio Pharma, INC. | $39.15 | 2025 | Attruby |
| Philips North America LLC | $31.14 | 2025 | Ecc Solutions |
| Amgen INC. | $23.92 | 2025 | Repatha |
| Novo Nordisk INC | $21.87 | 2025 | Wegovy |
| Lilly USA, LLC | $19.96 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charyl Hermann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.